Adagio Medical Holdings, Inc. (ADGM)

Stammdaten

Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.

Unternehmen & Branche

NameAdagio Medical Holdings, Inc.
TickerADGM
CIK0002006986
BoerseUS
SektorHealthcare
IndustrieMedical - Devices

Wertpapier & Kennzahlen

CUSIP
ISIN
TypCommon Stock
Marktkapitalisierung16,4 Mio. USD
Beta0,04
Dividendenrendite0,00 %

Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »

Finanzkennzahlen (SEC XBRL)

PeriodeFilingUmsatzNettoergebnisEPSAktivaEigenkapital
2025-12-3110-K0-25,084,000-1.5143,253,00012,402,000
2025-09-3010-Q0-10,118,000-0.6631,546,000-1,312,000
2025-06-3010-Q-3,947,000-0.3535,876,0008,666,000
2025-03-3110-Q-7,713,000-0.5141,338,00012,399,000
2024-12-3110-K269,000-53,763,000-3.7048,448,00019,912,000
2024-09-3010-Q132,0003,606,0000.02107,196,00076,561,000
2024-07-3010-Q53,000-8,235,000-8.34-148,315,000
2024-07-3010-K333,000-21,278,000-26.08-148,315,000
2024-06-3010-Q254,000-5,734,000-7.35-140,506,000
2024-03-3110-Q26,000-8,018,000-10.28-139,218,000
2023-12-3110-K300,000-36,590,000-48.166,825,000-132,023,000
2023-09-3010-Q41,000-10,761,000-14.15-123,507,000

Fondsaktivität (Vorquartalsvergleich)

Keine Fondsdaten für dieses Unternehmen vorhanden.

Insider-Transaktionen (12 Monate)

Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.

Top-Fondshalter

Keine Fondsdaten zu dieser Aktie vorhanden.

Hinweis

Erweitert ×